Osteoporosis: Prevention, Risk Factors, and Treatment Guide (2026)

Osteoporosis is often called a "silent disease" — and that description is apt. You don't feel your bones getting thinner. There's no pain, no warning. The first sign is often a fracture from a fall that wouldn't have been serious for a younger person, or sometimes a fracture from something as minor as a sneeze or stepping off a curb wrong. Osteoporosis affects an estimated 200 million people worldwide and causes over 8.9 million fractures annually — one every 3 seconds.

The encouraging reality: bone loss is largely preventable, and even established osteoporosis is highly treatable. The time to act is well before a fracture occurs.

Understanding Bone Biology: Why Bones Lose Density

Bone is living tissue, constantly being broken down (resorption) and rebuilt (formation) in a process called remodeling. In your 20s, formation outpaces resorption — building peak bone mass. This peaks around age 25–30. After about 35, resorption begins to slightly outpace formation — bone density gradually declines throughout adulthood.

In women, the menopause transition accelerates this loss dramatically. Estrogen normally suppresses osteoclast activity (bone breakdown cells). When estrogen drops at menopause, osteoclasts become overactive — women can lose 10–20% of their bone density in the first 5–7 years after menopause. This is why women have significantly higher osteoporosis rates than men.

Osteoporosis develops when bone density falls far enough, and bone microarchitecture deteriorates enough, that fracture risk becomes substantially elevated. The medical definition uses a T-score (comparison to a young healthy adult's peak bone mass):

Risk Factors: Who Is Most at Risk?

Non-Modifiable Risk Factors

• Female sex: Women have lower peak bone mass and experience accelerated menopause-related bone loss — accounting for 80% of osteoporosis diagnoses
• Age: Bone density declines progressively; fracture risk doubles with each decade over 50
• Family history: Maternal history of hip fracture roughly doubles your risk
• Ethnicity: White and Asian women have the highest risk; Black women have higher bone density and lower fracture risk despite similar osteoporosis prevalence
• Small body frame: Less bone mass to begin with means less reserve
• Previous fragility fracture: The strongest predictor of future fractures — fracture begets fracture

Modifiable Risk Factors

• Calcium deficiency: Inadequate calcium throughout life reduces peak bone mass and accelerates loss
• Vitamin D deficiency: Without vitamin D, calcium absorption drops to 10–15%; with adequate D it's 30–40%
• Physical inactivity: Bone responds to mechanical loading — weight-bearing and resistance exercise are essential for bone maintenance
• Smoking: Directly toxic to osteoblasts (bone-building cells); reduces estrogen levels
• Excessive alcohol: More than 2–3 drinks daily impairs osteoblast function
• Low body weight: BMI below 18.5 is a significant osteoporosis risk factor
• Eating disorders: Anorexia nervosa causes severe bone loss through multiple mechanisms

Medical Conditions and Medications That Cause Bone Loss

• Glucocorticoids (prednisone, prednisolone): The most common medication cause — prednisone ≥5mg daily for ≥3 months requires bone protection assessment. Glucocorticoid-induced osteoporosis (GIOP) is a major clinical problem
• Celiac disease and IBD: Malabsorption of calcium and vitamin D
• Rheumatoid arthritis: Direct bone-loss effects of inflammation plus frequent steroid use
• Hyperparathyroidism: PTH mobilizes calcium from bones
• Hyperthyroidism: Accelerates bone turnover
• Hypogonadism: Low testosterone in men, premature menopause in women
• Proton pump inhibitors: Reduce calcium absorption with long-term use
• Certain anticonvulsants: Interfere with vitamin D metabolism
• Androgen deprivation therapy: Used for prostate cancer — causes rapid bone loss

Building and Protecting Bone: Evidence-Based Prevention

Calcium: Getting the Right Amount

Calcium is the primary mineral in bone — about 99% of the body's calcium is stored in bones and teeth. Recommended intake:

Food sources first: The National Osteoporosis Foundation and most guidelines emphasize dietary calcium over supplements when possible. Best sources: dairy (300mg per serving), calcium-set tofu (250–350mg per 100g), fortified plant milks (300mg per cup), sardines with bones (350mg per 3oz), kale and bok choy (good calcium with low oxalate), fortified orange juice.

If supplementing: Calcium carbonate (take with food for best absorption), or calcium citrate (better absorbed without food; preferred in those on acid-suppressing medications). Don't exceed 500mg calcium in a single dose — absorption decreases with larger doses. Recent debate about calcium supplements and cardiovascular risk has not been definitively resolved — most guidelines still recommend supplements when dietary intake is insufficient, but food sources remain preferred.

Vitamin D: The Calcium Partner

Without adequate vitamin D, even high calcium intake is poorly utilized. Target vitamin D level: 30–50 ng/mL (75–125 nmol/L). Recommended supplemental dose: 800–2000 IU D3 daily for most adults over 50. See our complete vitamin D deficiency guide for full details.

Exercise: The Most Underutilized Bone-Builder

Bone responds to mechanical stress by becoming denser — the principle of Wolff's Law. The key: the exercise must be weight-bearing and/or involve impact or resistance. Swimming and cycling, despite their cardiovascular benefits, don't build bone because they're non-weight-bearing.

Best exercises for bone density:

• Resistance/strength training: The most potent bone stimulus — particularly exercises involving spine loading (deadlifts, squats, rows) and upper body loading (presses, rows). Multiple meta-analyses confirm resistance training increases lumbar spine and hip bone density by 1–3% in postmenopausal women
• High-impact activities: Jogging, jumping, aerobics, racquet sports — the impact stimulus is highly osteogenic. The LIFTMOR trial (2017) found that high-intensity resistance and impact training improved bone density in osteoporotic women more effectively than low-intensity exercise — 3.2% improvement at the femoral neck
• Walking: Beneficial for maintaining bone density in older adults and preventing falls, though less powerful than resistance or impact training
• Balance and flexibility training: Tai chi and yoga — not bone-building per se, but critically important for fall prevention, which is the primary way bone density translates to fracture prevention

Aim for: 2–3 sessions of resistance training per week (all major muscle groups), daily walking or weight-bearing activity, and balance training 2–3 times weekly for those over 65.

Lifestyle Factors

• Stop smoking: Even 5–10 years after quitting, bone density partially recovers; fracture risk decreases
• Limit alcohol: No more than 1–2 standard drinks per day
• Maintain healthy body weight: Both underweight (insufficient mechanical loading, hormonal effects) and obesity (though paradoxically protective in some ways through increased loading) relate to bone health — healthy weight with high lean muscle mass is optimal
• Adequate protein: Essential for bone matrix — 1.2g/kg/day supports bone health better than low-protein diets

Screening: When to Get a DEXA Scan

Bone mineral density (BMD) is measured by DEXA (dual-energy X-ray absorptiometry) scan — the gold standard for osteoporosis diagnosis. It measures density at the hip and lumbar spine and generates a T-score.

Screening recommendations:

• All women age 65 and older (US Preventive Services Task Force Grade B recommendation)
• Postmenopausal women under 65 with risk factors (using the FRAX risk assessment tool)
• Men age 70 and older, or younger men with significant risk factors
• Any person starting long-term glucocorticoid therapy
• Anyone who has had a fragility fracture

The FRAX tool (shef.ac.uk/FRAX) calculates 10-year fracture probability based on clinical risk factors — it helps determine who needs treatment even before DEXA, and who with osteopenia needs medication vs. lifestyle alone.

Medical Treatments for Osteoporosis

Bisphosphonates — First-Line Treatment

Bisphosphonates (alendronate, risedronate, ibandronate, zoledronic acid) inhibit osteoclast activity — slowing bone resorption while formation continues, resulting in net bone density gain. They reduce vertebral fracture risk by 40–70% and hip fracture risk by 20–40%.

Alendronate (Fosamax) is typically first choice — taken weekly on an empty stomach with a full glass of water, remain upright for 30 minutes. The main concern: osteonecrosis of the jaw (ONJ) and atypical femoral fractures — both are very rare (risk estimated at less than 1 in 10,000 with standard use) and are dwarfed by fracture prevention benefits. After 3–5 years, a "drug holiday" may be appropriate for lower-risk patients — discuss with your doctor.

Zoledronic acid (Reclast) — annual IV infusion; useful for those who can't tolerate oral bisphosphonates. Flu-like symptoms for 1–3 days after first infusion are common; premedication with acetaminophen helps.

Denosumab (Prolia)

A monoclonal antibody that inhibits RANK-L — a key signal activating osteoclasts. Subcutaneous injection every 6 months. Highly effective — reduces vertebral fractures by 68% and hip fractures by 40% (FREEDOM trial). Unlike bisphosphonates, not excreted through kidneys so safe in severe CKD. Important caveat: stopping denosumab causes rapid rebound bone loss — transition to bisphosphonate when stopping is essential.

Teriparatide and Abaloparatide — Anabolic Agents

These are parathyroid hormone analogues that actually build new bone rather than just slowing breakdown — making them more powerful than antiresorptive agents for severe osteoporosis. Teriparatide (Forteo) reduces vertebral fractures by 65% and non-vertebral fractures by 35% in postmenopausal women. Daily subcutaneous injection for up to 2 years; followed by antiresorptive therapy to preserve gains. Reserved for severe osteoporosis or treatment failure due to cost.

Romosozumab (Evenity)

The newest class — a sclerostin inhibitor that simultaneously builds bone and reduces resorption ("dual effect"). Monthly subcutaneous injection for 12 months only. Remarkable efficacy for high-risk patients. An FDA black box warning regarding cardiovascular risk means it's contraindicated within 1 year of heart attack or stroke.

Hormone Therapy

Estrogen-containing hormone therapy (HRT) prevents postmenopausal bone loss and reduces fracture risk. However, due to breast cancer and cardiovascular risks, it's not primarily used for osteoporosis unless also treating menopausal symptoms. Raloxifene (Evista) — a selective estrogen receptor modulator — reduces breast cancer and vertebral fracture risk but not hip fractures.

Fall Prevention: The Other Half of Fracture Prevention

Even excellent bone density doesn't prevent fractures if you fall frequently. For older adults, fall prevention is as important as bone density. Evidence-based strategies:

• Exercise programs focusing on balance and strength: Reduce falls by 15–35%
• Home hazard modification: Remove trip hazards, install grab bars, improve lighting
• Vision correction: Poor vision is a major fall risk factor
• Medication review: Sedatives, blood pressure medications, and multiple medications increase fall risk — work with your doctor to minimize this
• Hip protectors: Worn as padded underwear — reduce hip fracture risk when falls occur in high-risk individuals
• Adequate vitamin D: Vitamin D not only benefits bone but improves muscle strength and balance, reducing fall risk

Frequently Asked Questions